Creative Planning’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,174
Closed -$91K 4120
2017
Q2
$91K Sell
1,174
-326
-22% -$24.5K ﹤0.01% 2054
2017
Q1
$120K Buy
1,500
+326
+28% +$25.9K ﹤0.01% 1840
2016
Q4
$92K Buy
1,174
+174
+17% +$13.5K ﹤0.01% 1932
2016
Q3
$78K Sell
1,000
-25
-2% -$1.81K ﹤0.01% 2028
2016
Q2
$70K Sell
1,025
-105
-9% -$7.24K ﹤0.01% 1916
2016
Q1
$81K Buy
1,130
+105
+10% +$6.59K ﹤0.01% 1763
2015
Q4
$64K Buy
+1,025
New +$62.5K ﹤0.01% 1922
2015
Q2
Sell
-99
Closed -$5K 3387
2015
Q1
$5K Buy
+99
New +$4.38K ﹤0.01% 3567
2014
Q4
Sell
-38
Closed -$1K 4408
2014
Q3
$1K Buy
+38
New +$1.34K ﹤0.01% 3898

Other funds holding CMD

Creative Planning's CMD Position: Q3 2017 in Review

Creative Planning sold out of Cantel Medical Corporation (CMD) in Q3 2017, closing a stake of 1,174 shares — an estimated $91K sold.

Creative Planning first reported a position in CMD in Q3 2014 and held it in 9 quarters. The position peaked at $120K in Q1 2017. 231 funds tracked by Wall St. Rank hold CMD as of Q3 2017.

  • Creative Planning reported no remaining Cantel Medical Corporation position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 1,174 Cantel Medical Corporation shares in Q3 2017, an estimated $91K.
  • Creative Planning first reported a position in Cantel Medical Corporation in Q3 2014 and held it in 9 quarters.
  • Creative Planning's Cantel Medical Corporation position peaked at $120K in Q1 2017.
  • 231 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.